Short Term Estimates And Forecasts For Processa Pharmaceuticals Inc (PCSA)
Processa Pharmaceuticals Inc (NASDAQ:PCSA) has a beta value of 1.40 and has seen 3.5 million shares traded in the last trading session. The company, currently
Processa Pharmaceuticals Inc (NASDAQ:PCSA) has a beta value of 1.40 and has seen 3.5 million shares traded in the last trading session. The company, currently
In today’s recent session, 0.63 million shares of the Processa Pharmaceuticals Inc (NASDAQ:PCSA) have been traded, and its beta is 1.32. Most recently the company’s
In last trading session, Processa Pharmaceuticals Inc (NASDAQ:PCSA) saw 0.8 million shares changing hands with its beta currently measuring 1.31. Company’s recent per share price
During the last session, Processa Pharmaceuticals Inc (NASDAQ:PCSA)’s traded shares were 1.89 million, with the beta value of the company hitting 1.33. At the end
In the last trading session, 2.39 million shares of the Processa Pharmaceuticals Inc (NASDAQ:PCSA) were traded, and its beta was 1.33. Most recently the company’s
In the last trading session, 0.81 million shares of the Processa Pharmaceuticals Inc (NASDAQ:PCSA) were traded, and its beta was 1.33. Most recently the company’s
Processa Pharmaceuticals Inc (NASDAQ:PCSA)’s traded shares stood at 9.21 million during the last session, with the company’s beta value hitting 1.37. At the close of
Processa Pharmaceuticals Inc (NASDAQ:PCSA) has a beta value of 1.41 and has seen 1.26 million shares traded in the last trading session. The company, currently
© 2024, Powered by Smart TechOne